- Home
- GERN vs CHCO Comparison
GERN vs CHCO Comparison
Compare GERN & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- CHCO
- Stock Information
- Founded
- GERN 1990
- CHCO 1957
- Country
- GERN United States
- CHCO United States
- Employees
- GERN N/A
- CHCO N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- CHCO Major Banks
- Sector
- GERN Health Care
- CHCO Finance
- Exchange
- GERN Nasdaq
- CHCO Nasdaq
- Market Cap
- GERN 1.5B
- CHCO 1.7B
- IPO Year
- GERN 1996
- CHCO N/A
- Fundamental
- Price
- GERN $2.57
- CHCO $117.19
- Analyst Decision
- GERN Strong Buy
- CHCO Hold
- Analyst Count
- GERN 11
- CHCO 3
- Target Price
- GERN $6.82
- CHCO $118.00
- AVG Volume (30 Days)
- GERN 12.4M
- CHCO 46.6K
- Earning Date
- GERN 02-26-2025
- CHCO 01-23-2025
- Dividend Yield
- GERN N/A
- CHCO 2.70%
- EPS Growth
- GERN N/A
- CHCO 3.68
- EPS
- GERN N/A
- CHCO 7.89
- Revenue
- GERN $29,480,000.00
- CHCO $291,751,000.00
- Revenue This Year
- GERN $31,918.56
- CHCO N/A
- Revenue Next Year
- GERN $289.41
- CHCO $2.39
- P/E Ratio
- GERN N/A
- CHCO $14.85
- Revenue Growth
- GERN 9199.68
- CHCO 1.79
- 52 Week Low
- GERN $1.64
- CHCO $97.50
- 52 Week High
- GERN $5.34
- CHCO $137.28
- Technical
- Relative Strength Index (RSI)
- GERN 31.98
- CHCO 43.53
- Support Level
- GERN $2.49
- CHCO $117.04
- Resistance Level
- GERN $2.84
- CHCO $122.62
- Average True Range (ATR)
- GERN 0.15
- CHCO 2.63
- MACD
- GERN -0.01
- CHCO 0.03
- Stochastic Oscillator
- GERN 13.33
- CHCO 29.20
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About CHCO City Holding Company
City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.